New findings reveal how a co-receptor named TIM3 on T cells functions differently depending on its cellular context—a discovery that could aid in the development of drugs that target this co-receptor. @CMMBristol
https://t.co/Dq7V57x2a6
0
1
5
Replies
Approved PARP1 inhibitors overcome immunotherapy resistance in breast cancer, scientists identify a trio of proteins that recruit stem cells for skull repair, and more this week in the new issue of #ScienceSignaling. https://t.co/yj2bLq6MOI
4
9
32